137 related articles for article (PubMed ID: 6467185)
1. In vivo dosimetry of 4-aminobiphenyl in rats via a cysteine adduct in hemoglobin.
Green LC; Skipper PL; Turesky RJ; Bryant MS; Tannenbaum SR
Cancer Res; 1984 Oct; 44(10):4254-9. PubMed ID: 6467185
[TBL] [Abstract][Full Text] [Related]
2. Frequency of urination and its effects on metabolism, pharmacokinetics, blood hemoglobin adduct formation, and liver and urinary bladder DNA adduct levels in beagle dogs given the carcinogen 4-aminobiphenyl.
Kadlubar FF; Dooley KL; Teitel CH; Roberts DW; Benson RW; Butler MA; Bailey JR; Young JF; Skipper PW; Tannenbaum SR
Cancer Res; 1991 Aug; 51(16):4371-7. PubMed ID: 1868460
[TBL] [Abstract][Full Text] [Related]
3. Monitoring exposure to 4-aminobiphenyl via blood protein adducts.
Skipper PL; Green LC; Bryant MS; Tannenbaum SR; Kadlubar FF
IARC Sci Publ; 1984; (59):143-50. PubMed ID: 6545277
[TBL] [Abstract][Full Text] [Related]
4. Hemoglobin adducts of 4-aminobiphenyl in smokers and nonsmokers.
Bryant MS; Skipper PL; Tannenbaum SR; Maclure M
Cancer Res; 1987 Jan; 47(2):602-8. PubMed ID: 3791245
[TBL] [Abstract][Full Text] [Related]
5. The metabolism of 4-aminobiphenyl in rat. II. Reaction of N-hydroxy-4-aminobiphenyl with rat blood in vitro.
Heilmair R; Karreth S; Lenk W
Xenobiotica; 1991 Jun; 21(6):805-15. PubMed ID: 1949910
[TBL] [Abstract][Full Text] [Related]
6. CYP1A2 and NAT2 phenotyping and 3-aminobiphenyl and 4-aminobiphenyl hemoglobin adduct levels in smokers and non-smokers.
Sarkar M; Stabbert R; Kinser RD; Oey J; Rustemeier K; von Holt K; Schepers G; Walk RA; Roethig HJ
Toxicol Appl Pharmacol; 2006 Jun; 213(3):198-206. PubMed ID: 16405939
[TBL] [Abstract][Full Text] [Related]
7. Synthesis, characterization, and quantitation of a 4-aminobiphenyl-DNA adduct standard.
Beland FA; Doerge DR; Churchwell MI; Poirier MC; Schoket B; Marques MM
Chem Res Toxicol; 1999 Jan; 12(1):68-77. PubMed ID: 9894020
[TBL] [Abstract][Full Text] [Related]
8. Biomonitoring of smoke constituents: exposure to 4-aminobiphenyl and 4-aminobiphenyl hemoglobin adduct levels in nonsmokers and smokers.
Schorp MK; Leyden DE
Inhal Toxicol; 2010 Aug; 22(9):725-37. PubMed ID: 20433335
[TBL] [Abstract][Full Text] [Related]
9. N-acetyltransferase 2 phenotype but not NAT1*10 genotype affects aminobiphenyl-hemoglobin adduct levels.
Probst-Hensch NM; Bell DA; Watson MA; Skipper PL; Tannenbaum SR; Chan KK; Ross RK; Yu MC
Cancer Epidemiol Biomarkers Prev; 2000 Jun; 9(6):619-23. PubMed ID: 10868698
[TBL] [Abstract][Full Text] [Related]
10. Cytochrome P4501A2: enzyme induction and genetic control in determining 4-aminobiphenyl-hemoglobin adduct levels.
Landi MT; Zocchetti C; Bernucci I; Kadlubar FF; Tannenbaum S; Skipper P; Bartsch H; Malaveille C; Shields P; Caporaso NE; Vineis P
Cancer Epidemiol Biomarkers Prev; 1996 Sep; 5(9):693-8. PubMed ID: 8877060
[TBL] [Abstract][Full Text] [Related]
11. Analysis of 4-aminobiphenyl hemoglobin adducts in smokers and nonsmokers by pseudo capillary on-column gas chromatography- tandem mass spectrometry.
Seyler TH; Reyes LR; Bernert JT
J Anal Toxicol; 2010; 34(6):304-11. PubMed ID: 20663282
[TBL] [Abstract][Full Text] [Related]
12. Hemoglobin adducts of the human bladder carcinogen o-toluidine after treatment with the local anesthetic prilocaine.
Gaber K; Harréus UA; Matthias C; Kleinsasser NH; Richter E
Toxicology; 2007 Jan; 229(1-2):157-64. PubMed ID: 17129655
[TBL] [Abstract][Full Text] [Related]
13. Relationship between environmental tobacco smoke exposure and carcinogen-hemoglobin adduct levels in nonsmokers.
Hammond SK; Coghlin J; Gann PH; Paul M; Taghizadeh K; Skipper PL; Tannenbaum SR
J Natl Cancer Inst; 1993 Mar; 85(6):474-8. PubMed ID: 8445675
[TBL] [Abstract][Full Text] [Related]
14. Haemoglobin adducts of aromatic amines in people exposed to cigarette smoke.
Bryant MS; Vineis P; Skipper PL; Tannenbaum SR
IARC Sci Publ; 1988; (89):133-6. PubMed ID: 3198197
[TBL] [Abstract][Full Text] [Related]
15. Covalent binding of 2-amino-3,8-dimethylimidazo[4,5-f]quinoxaline to albumin and hemoglobin at environmentally relevant doses. Comparison of human subjects and F344 rats.
Dingley KH; Freeman SP; Nelson DO; Garner RC; Turteltaub KW
Drug Metab Dispos; 1998 Aug; 26(8):825-8. PubMed ID: 9698300
[TBL] [Abstract][Full Text] [Related]
16. Analytical methods for assessing exposure to 4-aminobiphenyl based on protein adduct formation.
Skipper PL; Bryant MS; Tannenbaum SR; Groopman JD
J Occup Med; 1986 Aug; 28(8):643-6. PubMed ID: 3746485
[TBL] [Abstract][Full Text] [Related]
17. Measurement of 4-aminobiphenyl-hemoglobin adducts in lung cancer cases and controls.
Weston A; Caporaso NE; Taghizadeh K; Hoover RN; Tannenbaum SR; Skipper PL; Resau JH; Trump BF; Harris CC
Cancer Res; 1991 Oct; 51(19):5219-23. PubMed ID: 1913645
[TBL] [Abstract][Full Text] [Related]
18. Immunochemical quantitation of DNA adducts derived from the human bladder carcinogen 4-aminobiphenyl.
Roberts DW; Benson RW; Groopman JD; Flammang TJ; Nagle WA; Moss AJ; Kadlubar FF
Cancer Res; 1988 Nov; 48(22):6336-42. PubMed ID: 3180051
[TBL] [Abstract][Full Text] [Related]
19. Identification of N-(deoxyguanosin-8-yl)-4-azobiphenyl by (32)P-postlabeling analyses of DNA in human uroepithelial cells exposed to proximate metabolites of the environmental carcinogen 4-aminobiphenyl.
Hatcher JF; Swaminathan S
Environ Mol Mutagen; 2002; 39(4):314-22. PubMed ID: 12112383
[TBL] [Abstract][Full Text] [Related]
20. Synthesis, characterization, and 32P-postlabeling of N-(deoxyguanosin)-4-aminobiphenyl 3'-phosphate adducts.
Haack T; Boche G; Kliem C; Wiessler M; Albert D; Schmeiser HH
Chem Res Toxicol; 2004 Jun; 17(6):776-84. PubMed ID: 15206898
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
